HLA-B27 and its pathogenic role

Journal of Clinical Rheumatology

Volumn 14, Issue 1, 2008, Pages 50-52

  Khan, Muhammad Asim ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA B27 ANTIGEN;

ACUTE ANTERIOR UVEITIS; ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENTERITIS; GENE FREQUENCY; GENETIC HETEROGENEITY; HOMOZYGOSITY; HUMAN; HYPOTHESIS; IMMUNIZATION; IRIDOCYCLITIS; LABORATORY TEST; MEDICAL EDUCATION; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOLOGY; SCREENING TEST; SHORT SURVEY; SPONDYLOARTHROPATHY; ULCERATIVE COLITIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGY; REVIEW; SPONDYLARTHRITIS;

GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; PHENOTYPE; SPONDYLARTHRITIS;

EID: 44449106585     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181637a38     Document Type: Short Survey

References (15)

1. Thorsby E, Kissmeyer-Nielsen F. HL-A antigens and genes. III. Production of HL-A typing antisera of desired specificity. Vox Sang. 1969;17:102-111.
2. Akkoc N, Khan MA. Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In: Weisman MH, Reveille JD, van der Heijde D, eds. Ankylosing Spondylitis and the Spondyloarthropathies: A Companion to Rheumatology. London, Mosby: Elsevier; 2006:117-131.
3. Khan MA. Clinical application of HLA-B27 test in rheumatic diseases: a current perspective. Arch Intern Med. 1980;140:177-180.
4. Khan MA, Khan MK. Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Intern Med. 1982;96:70-76.
5. Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002;136: 896-907.
6. Khan MA. Ankylosing spondylitis: clinical features. In: Hochberg M, Silman A, Smolen J, et al, eds. Rheumatology, 3rd ed. London, Mosby: A Division of Harcourt Health Sciences Ltd.; 2003:1161-1181.
7. Khan MA, Kushner I, Braun WE. Comparison of clinical features of HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum. 1977;20:909-912.
8. Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum. 2005;52:269-274.
9. Khan MA, Kushner I, Braun WE, et al. HLA-B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens. 1978;11:434-438.
10. Jaakkola E, Herzberg J, Laiho K, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis. 2006;65:775-780.
11. Khan MA. Ankylosing spondylitis and heterogeneity of HLA-B27. Semin Arthritis Rheum. 1988;18:134-141.
12. Khan MA, Ball EJ. Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2002;16:675-690.
13. Khan MA, Mathieu A, Sorrentino R, et al. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev. 2007;6:183-189.
14. Lopez de Castro J. HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett. 2007;108:27-33.
15. Turner MJ, Delay ML, Bai S, et al. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum. 2007;56:215-223.